DNA Script Raises $38.5 Million in Series B Financing

PARIS–(BUSINESS WIRE)–DNA Script today announced an oversubscribed Series B fundraising of $38.5M led by LSP, one of Europe?s largest and most experienced healthcare investment firms. Bpifrance, through its Large Venture fund, joined the round, alongside existing investors Illumina Ventures, M. Ventures, Sofinnova Partners, Kurma Partners and Idinvest Partners. The proceeds will enable DNA Script to accelerate the development of the company?s first products based on its industry-leading enzym